PDF: Update on Drugs & Devices: January – February 2023

$1.99

PDF Download: Update covering: Deucravacitinib tablets (Sotyktu™), mRNA vaccine + pembrolizumab IV combination therapy (mRNA-4157/V940 + Keytruda®), Adalimumab-aacf SC injection (Idacio®), Dupilumab for SC injection (Dupixent®), and Spesolimab IV injection (Spevigo®).

Read online:
Update on Drugs & Devices: January – February 2023

Category: Dermatology

PDF: Update on Drugs & Devices: January – February 2023

Related products

PDF: Non-Invasive Gene Expression Testing to Rule Out Melanoma

PDF: Hydrogen Peroxide Topical Solution, 40% for the Treatment of Seborrheic Keratoses

PDF: Update on Drugs & Devices: September – October 2019

PDF: Real-World Efficacy of Azelaic Acid 15% Gel for the Reduction of Inflammatory Lesions of Rosacea